Founded in 2001, SWS Hemodialysis Care Co., Ltd. (“SWS”) provides integrated blood purification solutions of better care for renal failure and critically ill patients worldwide. Our products and services include blood purification devices, disposables, intelligent dialysis management system, and dialysis center services.

SWS is listed publicly on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange (SSE: 688410), the very first in China′s blood purification industry. As a full-industry-chain company, SWS has 3 subsidiaries: TWT Bio-tech, KMJ Dialysis Co., Ltd., and one SINO-Swiss JV, SD Medical specialized in world′s state of art dialyzers.

Innovation is in the DNA of SWS. Over the past two decades, SWS has secured key technologies, research and engineering methods in blood purification. We own independent intellectual property rights and hundreds of authorized patents. Acknowledged as a national demonstration enterprise in technological innovation, SWS has set up technology and engineering research centers and an on-site postdoctoral workstation at national level. As a market pioneer in China, SWS has also participated in establishing three national standards and five industry standards.

Improving the wellness of patients is SWS's utmost priority and ultimate goal. Better care to patients is made possible with our on-going commitment to integrated blood purification technology. With thousands of installed units worldwide, numerous patients with kidney diseases have benefited from our quality products and tailored services. SWS devices are CE marked and the quality system is ISO 13485:2016 certified. SWS has been recognized as one of the most reliable partners by top-notch Chinese Grade A hospitals and international medical institutions in more than 80 countries and regions.